what this node claims
AlphaFold metrics / MC1R
Model-quality receipt for the fold. It is not biological validation.
vertical proof spine
evidence / risk instrument
53%
low debt pressure
21%
81%structurestrong
pLDDT 80.51
78%evidenceusable
grade B
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine
proof completeness
33% missing target, candidate, finding, export- 01 target
- 02 fold
- 03 alphafold metric
- 04 candidate
- 05 finding
- 06 export
Metrics and receipt inputs
- confidence band
- confident
- confidence pct
- 80.51
- coverage context
- missing or not linked
- interpretation
- usable fold context with explicit model-confidence limits
- pae context
- missing or not linked
- plddt avg
- 80.51
- sequence length
- 0
AlphaFold metrics visual
Confident backbone model
317 residues / min 26.03 / max 98.38 / source alphafold db
Very high
35.0%
111 residues / >=90
Confident
47.0%
149 residues / 70-89
Low
7.3%
23 residues / 50-69
Very low
10.7%
34 residues / <50
usable fold context with explicit model-confidence limits
Near-complete coverage / observed 317 of 317 residues.
- residues 1-34 / mean 40.89
- residues 226-244 / mean 54.93
- residues 316-317 / mean 60.66
- residues 300-301 / mean 67.91
proof debt register
21%
Visible limits, not hidden cleanup.
Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.